Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis.
作者信息
Simón J A, Burgos-Vargas R
出版信息
Ann Rheum Dis. 2006 Nov;65(11):1535-6. doi: 10.1136/ard.2006.053397.
Abstract
摘要
相似文献
1
Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis.墨西哥风湿病学家对强直性脊柱炎国际工作组的评估以及欧洲抗风湿病联盟关于强直性脊柱炎管理建议的认同。
Ann Rheum Dis. 2006 Nov;65(11):1535-6. doi: 10.1136/ard.2006.053397.
2
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.一项关于在强直性脊柱炎中开始使用肿瘤坏死因子阻断剂的国际研究。
Ann Rheum Dis. 2006 Dec;65(12):1620-5. doi: 10.1136/ard.2005.042630. Epub 2006 Feb 7.
3
[Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology].[强直性脊柱炎治疗指南及其对墨西哥风湿病学的影响]
Gac Med Mex. 2009 Jan-Feb;145(1):41-9.
4
ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version.ASAS/EULAR关于强直性脊柱炎管理的建议：患者版
Ann Rheum Dis. 2009 Sep;68(9):1381-6. doi: 10.1136/ard.2008.096073. Epub 2008 Oct 17.
5
Axial Spondyloarthritis Treatment Recommendations and Disease Activity Monitoring in Clinical Practice: Results of an Online Survey.轴向型脊柱关节炎治疗推荐和临床实践中的疾病活动监测：一项在线调查的结果。
J Rheumatol. 2024 May 1;51(5):472-478. doi: 10.3899/jrheum.2023-0894.
6
7
Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion.强直性脊柱炎患者治疗与监测的临床及实验室随访：基于已发表证据和专家意见制定临床实践建议
Joint Bone Spine. 2007 Jul;74(4):330-7. doi: 10.1016/j.jbspin.2007.04.002. Epub 2007 May 30.
8
[Patient evaluation of the German version of the ASAS/EULAR recommendations for the management of ankylosing spondylitis].[德国版ASAS/EULAR强直性脊柱炎管理推荐的患者评估]
Z Rheumatol. 2008 Dec;67(8):694-700, 702. doi: 10.1007/s00393-008-0371-9.
9
Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion.强直性脊柱炎的药物治疗（不包括生物疗法）：基于已发表证据和专家意见制定临床实践建议。
Joint Bone Spine. 2007 Jul;74(4):346-52. doi: 10.1016/j.jbspin.2007.04.003. Epub 2007 May 30.
10
[Danish recommendations on treatment of ankylosing spondylitis and spondyloarthritis based on multinational project initiative].[基于跨国项目倡议的丹麦强直性脊柱炎和脊柱关节炎治疗建议]
Ugeskr Laeger. 2008 Dec 1;170(49):4044-50.
引用本文的文献
1
Agreement of Turkish physiatrists with the assessment in spondyloarthritis international society and the European league against rheumatism recommendations for the management of ankylosing spondylitis and rheumatoid arthritis.土耳其物理治疗师对国际脊柱关节炎协会的评估以及欧洲抗风湿病联盟关于强直性脊柱炎和类风湿关节炎管理建议的认同。
Open Rheumatol J. 2012;6:1-5. doi: 10.2174/1874312901206010001. Epub 2012 Mar 16.
本文引用的文献
1
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.强直性脊柱炎管理的当前证据：针对强直性脊柱炎ASAS/EULAR管理建议的系统文献综述
Ann Rheum Dis. 2006 Apr;65(4):423-32. doi: 10.1136/ard.2005.041129. Epub 2005 Aug 26.
2
ASAS/EULAR recommendations for the management of ankylosing spondylitis.美国脊柱关节炎协会/欧洲抗风湿病联盟关于强直性脊柱炎管理的建议。
Ann Rheum Dis. 2006 Apr;65(4):442-52. doi: 10.1136/ard.2005.041137. Epub 2005 Aug 26.
Zotero 插件